Heron Therapeutics, Inc. (HRTX) Company Total Revenue

Corporate emblem and logo of Heron Therapeutics Inc (HRTX)

How can pain and oncology therapies be integrated into hospital protocols? Actual sales for Heron Therapeutics demonstrate current dynamics, where 0.15 reflects the latest metric value. The solution lies in surgeons' trust in Heron Therapeutics innovations that reduce opioid load. The business's stability is ensured by proprietary Zynrelef polymer systems, which protect profitability from generic expansion in the supportive therapy segment.

HRTX - Heron Company Revenue over the range 07/04/2022 - 11/18/2026

Analytical breakdowns for Heron (HRTX)

- stock value and consensus price forecast:
General company analysis:Heron Therapeutics Inc - HRTX
Mass-produced product of Heron Therapeutics, Inc.

This indicator captures daily cash inflows from product sales, excluding quarterly distortions to assess real demand. Rising values confirm the business's liquidity, though caution is required to avoid overpaying for the asset. By analyzing the company's aggregate sales figures, an investor can track the dynamics of commercial expansion. For Heron Therapeutics (HRTX), this reflects market recognition of its innovative analgesics. Stable revenue confirms surgeons' confidence in drugs that reduce opioid dependence.